Week of May 23, 2022 | Vol. 11, Issue 21
Events Hosted or Attended by Bourne Partners
June 13-16, 2022 - San Diego, CA
June 19-23, 2022 - Chicago IL
August 27-29, 2022 - Boston, MA
September 22-23, 2022 - New Brunswick, NJ
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

For a complete trading comp analysis (including the individual equities that comprise the sub sectors), click on the table. 

Note: data reflects prior week close.
Insight Into Healthcare Related Industries
Representative Current Retained Sell-Side And Partnering Opportunities
Project Aman
M&A / Capital Advisory |OTC | Branded Consumer Health

Project Gateway
Sell-side | Pharma | Generic Pharmaceuticals

Project Panther
Sell-side| CDMO | Consumer Health and Medical Device
Project Power Play
Buy-side | Specialty Pharma | In-license and acquire approved Rx products including legacy brands, generics, and niche launch-ready products

Project Trident
Buy-side | Generic Pharma | Manufacturing liquid generics
A Sampling of Industry Headlines From Last Week

Tanner was honored to serve as the presenting sponsor of The Max Foundation's annual Max Gala, and to help amplify the voices of cancer patients around the world. Through the support of many, the gala raised more than $260,000 in support of Max's mission to accelerate health equity. Learn more about Tanner's partnership with Max and the impacts of the Max Access Solutions program.

While the global pandemic has caused significant disruption to the supply chain, it is still possible to maintain a robust and reliable delivery network to minimize delays in shipments. Learn how Tanner Pharma Group has successfully maneuvered supply chain challenges during the Covid-19 pandemic here.